Chronic diseases—such as diabetes, cardiovascular disorders, and chronic respiratory conditions—account for over 70% of global deaths annually, with late diagnosis being a primary contributor to poor outcomes. While machine learning (ML) models have shown promise in early detection, they often suffer from limited generalizability, data heterogeneity, and insufficient interpretability in clinical settings. This paper introduces a novel hybrid quantum-classical machine learning (HQML) framework that synergistically combines the pattern recognition power of classical deep neural networks with the high-dimensional optimization capabilities of quantum algorithms to enhance diagnostic accuracy, robustness, and early signal detection in chronic disease prediction. Using multimodal electronic health record (EHR) data—including clinical, genomic, and lifestyle variables—we train a quantum-enhanced feature selector followed by a classical interpretable classifier (e.g., SHAP-augmented XGBoost). The quantum component leverages a variational quantum circuit to identify non-linear, high-order feature interactions that classical methods often miss. Validated on datasets from the National Health and Nutrition Examination Survey (NHANES) and UK Biobank, our model achieves 94.7% AUC for type 2 diabetes prediction five years before clinical diagnosis—outperforming state-of-the-art baselines by 6.2%. Crucially, the framework maintains interpretability through post-hoc explainability and reduces data bias via fairness-aware quantum embedding. This research bridges quantum computing and public health, offering a scalable, ethically grounded diagnostic paradigm. By enabling earlier, more accurate, and equitable predictions, the HQML framework has significant potential to transform preventive care and reduce the global burden of chronic disease.
Chronic diseases—such as diabetes, cardiovascular disorders, and chronic respiratory conditions—account for over 70% of global deaths annually, with late diagnosis being a primary contributor to poor outcomes. While machine learning (ML) models have shown promise in early detection, they often suffer from limited generalizability, data heterogeneity, and insufficient interpretability in clinical settings. This paper introduces a novel hybrid quantum-classical machine learning (HQML) framework that synergistically combines the pattern recognition power of classical deep neural networks with the high-dimensional optimization capabilities of quantum algorithms to enhance diagnostic accuracy, robustness, and early signal detection in chronic disease prediction. Using multimodal electronic health record (EHR) data—including clinical, genomic, and lifestyle variables—we train a quantum-enhanced feature selector followed by a classical interpretable classifier (e.g., SHAP-augmented XGBoost). The quantum component leverages a variational quantum circuit to identify non-linear, high-order feature interactions that classical methods often miss. Validated on datasets from the National Health and Nutrition Examination Survey (NHANES) and UK Biobank, our model achieves 94.7% AUC for type 2 diabetes prediction five years before clinical diagnosis—outperforming state-of-the-art baselines by 6.2%. Crucially, the framework maintains interpretability through post-hoc explainability and reduces data bias via fairness-aware quantum embedding. This research bridges quantum computing and public health, offering a scalable, ethically grounded diagnostic paradigm. By enabling earlier, more accurate, and equitable predictions, the HQML framework has significant potential to transform preventive care and reduce the global burden of chronic disease.
Early diagnosis of chronic diseases is paramount to improving patient survival rates, optimizing treatment trajectories, and mitigating escalating healthcare expenditures. While the recent explosion of heterogeneous healthcare data presents robust opportunities for predictive modeling, it simultaneously introduces severe computational bottlenecks regarding data dimensionality and non-linear complexity. This paper proposes a novel, high-performance hybrid prediction framework that seamlessly fuses classical machine learning topologies with Variational Quantum Circuits (VQCs) within a Quantum Machine Learning (QML) paradigm. The proposed architecture targets the multi-classification and risk profiling of five high-prevalence chronic conditions: diabetes, cardiovascular disease, breast cancer, chronic liver disease, and chronic kidney disease This project introduces “Quantum Health,” a Quantum Machine Learning (QML)-based multi disease prediction system that integrates classical and quantum computing to enhance diagnostic performance. It employs five quantum-enhanced models: Quantum Random Forest for breast cancer, Quantum Neural Network for diabetes, Quantum k-Nearest Neighbors (QkNN) for heart disease, Quantum AdaBoost for liver disease, and Quantum Naive Bayes for kidney disease. The models are evaluated using both classical methods and PennyLane simulations, enabling direct comparison of performance. The system is deployed as a Flask-based web application featuring a user-friendly dashboard, disease-specific prediction modules, prediction history with CSV export, and an analytics dashboard comparing classical and quantum accuracies. Each module provides predictions, confidence scores, and feature importance insights. Unlike monolithic classical models, our approach incorporates a parameterized quantum layer that maps low-dimensional classical medical vectors into high-dimensional Hilbert spaces, capturing intricate, non-linear correlations that evade classical kernels. Experimental evaluations executed on simulated quantum backends demonstrate that the proposed Quantum Hybrid Model drastically outperforms conventional baselines, achieving an overall classification accuracy of 96.8% and an Area Under the Curve (AUC) of 98.4%. The findings establish that integrating quantum circuit state vectors with ensemble classical architectures provides a scalable, computationally efficient, and highly generalizable paradigm for next-generation clinical decision support systems.
Cardiovascular diseases remain a leading global health challenge, driving the need for advanced, accurate diagnostic tools. While classical machine learning (ML) models like XGBoost have achieved significant success in medical diagnosis, they often face challenges related to accuracy plateaus and model explainability in complex, high-dimensional data spaces. Quantum machine learning (QML) emerges as a promising paradigm to potentially overcome these limitations by leveraging quantum computational advantages. This study aims to develop and evaluate a hybrid quantum-classical pipeline for the early detection of heart disease. We integrate robust data preprocessing—including missing value imputation, feature engineering, SMOTE for class balancing, and PCA for dimensionality reduction—with two classification approaches: a classical XGBoost model and a quantum Variational Quantum Classifier (VQC). Our results demonstrate that the XGBoost model achieves strong performance with an accuracy of 88.52% and an F1-score of 0.8852 on an imbalanced test set. While the VQC model did not surpass the classical baseline in the current noisy simulation environment, it shows theoretical promise. This work highlights the practical challenges of current QML and outlines a clear pathway for future research towards achieving a quantum advantage in clinical decision support systems.
Prompt diagnosis of disease is a strong driver for decreasing mortality, improving patient care and healthcare expenditures. Classical machine learning (ML), which has shown great potential in bolstering predictive modeling throughout oncology, cardiology, and neurology, runs the risk of excessive data dimensionality along with high computational complexity. Quantum computing is an exciting new paradigm for computation that takes advantage of superposition and entanglement which can be beneficial in learning patterns in high-dimensional spaces and for kernel-based learning. This review provides a systematic summary of the preliminary work on quantum machine learning (QML) with empirical applications to early disease diagnosis, while emphasizing its theoretical foundations, algorithmic developments and application in healthcare. We scope the conversation on quantum support vector machines, variational quantum classifiers, quantum kernels and hybrid architectures for a quantum classical. We also examine current hardware limitations in the NISQ era and assess how close these methods are to being ready for translation into public health applications. Although widespread clinical application is still far away, hybrid QML approaches are finding utility in low-data and high-complexity settings. We conclude with a discussion of research challenges, regulation and strategy towards realizing such quantum-enhanced precision diagnostics through U.S. public health innovation initiatives
Prompt diagnosis of disease is a key determinant in reducing mortality, improving patient care and decreasing healthcare costs. Despite the success of classical machine learning (ML) in improving predictive modeling across oncology, cardiology, and neurology, growing data dimensionality and computational complexity remain ongoing barriers. Quantum computing based on superposition and entanglement is a promising computational paradigm that shows potential advantages in high-dimensional pattern recognition and kernel-based learning. This review aims to systematically summarize preliminary work on quantum machine learning (QML) with empirical applications for early disease diagnosis, focusing on its theoretical underpinnings in addition to its algorithmic design and use in healthcare. We then frame the discussion with respect to quantum support vector machines and variational quantum classifiers, quantum kernels, as well as hybrid quantum–classical architectures. We further evaluate existing hardware constraints in the noisy intermediate-scale quantum (NISQ) era and appraise translational maturity for integration into public health. While clinical deployment is still far from broad, hybrid QMLs are proving useful in low-data and complex-feature contexts. We end with research challenges, regulatory guidance, and strategic directions towards enabling quantum-enhanced precision diagnostics aligned with U.S. public health innovation initiatives.
Cardiovascular diseases (CVDs) continue to be the leading global cause of death, requiring innovative approaches for early detection and accurate prediction. This study explores the transformative potential of quantum-enhanced machine learning (queml) models in cardiovascular disease prediction, addressing the limitations of conventional diagnostic approaches. Using extensive datasets including the Kaggle Heart Disease Dataset of 1,190 patient records and the Cleveland/State Registry datasets, the quantum-enhanced models show superior performance over traditional machine learning approaches, with QCVNET achieving 91.73% accuracy and queml showing a 0.6% improvement in accuracy, while reducing training time from 862.5 µs to 670 µs per cycle. Key physiological parameters including diabetes indicators, LDL cholesterol, HDL cholesterol, and triglycerides were incorporated as predictive features. The IQCNN framework achieved 91% classification accuracy at a learning rate of 70%, significantly outperforming the Bi-LSTM and CNN approaches. Comparative analysis revealed exceptional AUC scores of 96.43% and 97.78% for the hybrid models, establishing quantum-enhanced machine learning as a highly effective solution for cardiovascular risk assessment and early detection systems.
Abstract Chronic Kidney Disease (CKD) is a progressive and potentially fatal condition that is often diagnosed at advanced stages due to its asymptomatic nature in early progression. Accurate early prediction is challenging because of limited, heterogeneous clinical data and complex nonlinear relationships among biomarkers. This paper proposes HCF-QNet, a hybrid quantum–classical learning framework for robust CKD prediction. The proposed approach integrates three complementary components: optimized feature selection, contrastive representation learning, and variational quantum classification. Initially, a Grey Wolf Optimizer (GWO) is employed to select the most informative clinical features, reducing redundancy and dimensionality. The selected features are then transformed into a compact latent space using a supervised contrastive encoder, which enhances intra class compactness and inter class separability. These embeddings are subsequently processed by an 8-qubit Variational Quantum Neural Network (VQNN) with ring-based entanglement, enabling expressive nonlinear modeling beyond classical classifiers. A two-stage training strategy is adopted, where the encoder is contrastively pretrained and frozen during quantum fine-tuning to ensure stable optimization. The model is evaluated on the UCI CKD dataset using five fold cross-validation. Experimental results demonstrate an average accuracy of 99.75%, achieving better predictive performance than most existing classical machine learning and deep learning approaches. The results highlight the potential of hybrid quantum–classical models for accurate medical diagnosis on small and heterogeneous clinical datasets.